Running Title: PPAR-γ, RXR-α, and VDR Expressions in Periodontitis

计划入组 45 人 · 首次发布于 2019 年 7 月 12 日

PPAR, RXR, and VDR Expressions in Diabetes

计划入组 45 人 · 首次发布于 2020 年 1 月 29 日

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

计划入组 110 人 · 首次发布于 2009 年 6 月 23 日

γ-Aminobutyric

Rx

PPAR (Autobahn Therapeutics)

MyxV_CD47/IFN-γ

Wuhan Healthgen Biotechnology Corp.

Pear Therapeutics, Inc.

United States

Par Pharmaceutical, Inc.

United States

Zydus Therapeutics Receives FDA Priority Review for Saroglitazar in Primary Biliary Cholangitis

Lanifibranor Phase 1 Trial Launches in Japan for MASH Treatment Development

PPAR-gamma Pathway Modulation Enhances NECTIN4-Targeted CAR-T Therapy for Bladder Cancer